Zobrazeno 1 - 10
of 59
pro vyhledávání: '"M. Fagola"'
Publikováno v:
Blood Coagulation & Fibrinolysis. 9:499-506
Low-molecular-weight heparins (LMWHs) have been shown to be effective in the prevention of deep vein thrombosis (DVT) after major orthopaedic surgery, such as total hip replacement (THR). The efficacy and safety of two LMWHs, reviparin and enoxaparin
Publikováno v:
The Journal of Bone and Joint Surgery. British volume. :9-13
Bilateral venography was performed between 12 and 15 days after total hip replacement in 745 consecutive patients, all of whom had heparin prophylaxis. Of these, 81 patients (10.8%) showed evidence of recent deep vein thrombosis: 23 (3%) distal, 44 (
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 9(6)
Low-molecular-weight heparins (LMWHs) have been shown to be effective in the prevention of deep vein thrombosis (DVT) after major orthopaedic surgery, such as total hip replacement (THR). The efficacy and safety of two LMWHs, reviparin and enoxaparin
Publikováno v:
Seminars in thrombosis and hemostasis. 19
Publikováno v:
The Journal of bone and joint surgery. British volume. 73(3)
Enoxaparin, a low-molecular-weight heparin, has been used together with spinal or general anaesthesia in a prospective, randomised study of 188 consecutive elective hip replacements. Bilateral venography was performed on all patients on day 13 after
Publikováno v:
Seminars in thrombosis and hemostasis. 17
Publikováno v:
Acta chirurgica Scandinavica. Supplementum. 556
The main results of three successive prospective clinical trials which represent the successive steps in the definition of once-daily dosing of enoxaparin in elective hip surgery are demonstrated. In the first trial, a dose of 40 mg/day (4000 anti-Fa
Publikováno v:
Thrombosis Research. 65:S21
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 16:152-158
The effect of Enoxaparin in the prevention of thromboembolism after total hip prothesis has been controlled by phlebography. 228 consecutives patients were studied with 4 dose regimens: 60 mg once a day, 40 mg once a day, and 30 and 20 mg twice a day
Publikováno v:
Revue de chirurgie orthopedique et reparatrice de l'appareil moteur. 70(1)
Two series of patients on which total hip or knee prostheses had been inserted were studied. In the first series (150 cases), the patients were treated with low molecular Dextran and subcutaneous sodium heparin at a constant dosage. The Howell test w